and QRS duration. We identified 52 loci that were subsequently interrogated using bioinformatics and experimental approaches to gain more insights into the biological mechanisms regulating cardiac mass and QRS parameters.
METHODS
Additional details about the methods of our study can be found in the Online Appendix.
Our study design is summarized in Online Figure 1 .
Briefly, we combined summary statistics from 24 studies for up to 2,766,983 autosomal single nucleotide polymorphisms (SNPs) using an inverse-variance fixed-effects meta-analysis for each QRS trait. We performed replication testing for loci showing suggestive association (1 Â 10 À8 < p < 5 Â 10 À7 ) (Online Tables 1 and 2 ). The threshold for genome-wide significance was set at p < 1 Â 10 À8 .
We performed an intersection between SNPs and regions of deoxyribonuclease hypersensitivity sites 
RESULTS
Characteristics of studies, participants, genotyping arrays, and imputation are summarized in Online Tables 1 and 2 12-leadsum, and 9 with QRS duration (Online Table 5 ).
Collectively, the total variance explained by the 52 sentinel SNPs for the QRS traits was between 2.7%
(Sokolow-Lyon) and 5.0% (QRS duration) (Online Table 7 ). At some loci, we found evidence for
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Genetic Loci Influencing Myocardial Mass multiple independent associations with QRS phenotypes at p < 10 À8 in conditional analyses (7) (Online with heart rate (sinus node function) (Online Table 6 Table 9 , Online Appendix).
FUNCTIONAL ANNOTATION OF THE QRS ASSOCIATIONS.
To better capture common sequence variants at the 52 loci, we queried the 1000 Genomes Project dataset van der Harst et al.
Genetic Loci Influencing Myocardial Mass S E P T E M B E R 2 7 , 2 0 1 6 : 1 4 3 5 -4 8 the total number of the 52 loci overlapped by each feature is shown (right). (E) SNPs (p < 1 Â 10 À8 ) were also significantly enriched for various factors in the human heart, mouse heart, and the HL-1 cell line. CI ¼ confidence interval; TSS ¼ transcription start site; other abbreviations as in Figure 1 .
Genetic Loci Influencing Myocardial Mass (p < 10 À8 ) in DHS was strongest within the first 100 base pairs around the sentinel variants ( Figure 2B ).
Additionally, there was a strong enrichment for histone marks and chromatin states (13) associated with active enhancers, promoters, and transcription in the human heart; by contrast, no enrichment was observed for transcriptionally repressive histone marks or states ( Figures 2C and 2D , Online Figure 5 ).
Strikingly, we observed increasing enrichment of activating histone marks at the identified QRS loci during the process of differentiating mouse embryonic stem cells into cardiomyocytes (Online Figure 6 ).
Altogether, these findings are consistent with earlier observations of selective enrichment of traitassociated variants within DHS of specific cells of tissue types (10) , and they point to a regulatory role of the QRS-associated loci during cardiac development.
We next surveyed our genome-wide significant SNPs in DHS for perturbation of transcription factor (TF) recognition sequences, because these sites can point directly to binding events (Online Appendix). Of the 22 sentinel SNPs in human fetal heart DHS, 11 are predicted to alter TF recognition sequences (Online Table 11 ). When considering all genome-wide significant SNPs (p < 10 À8 ) as well as those in high LD Figure 1 . We validated several candidate regulatory regions identified earlier as heart enhancers in vivo.
Activity of 4 exemplar novel human cardiac enhancers in embryonic transgenic mice stained for LacZ enhancer reporter activity are shown in Figure 3A .
Recently, rs6801957 (Figure 1 ) in the SCN5A/SCN10A
locus was reported to influence the activity of a regulatory element affecting SCN5A expression (16,17).
Conditional analysis (Online Table 8 genes nearest to the sentinel SNP and any other genes within 10 kb (56 genes) ( Figure 1) ; 2) genes containing a nonsynonymous SNP in high LD (r 2 > 0.8) with the sentinel SNP (11 genes) (Online Table 10 ); 3) proteincoding genes with cis-eQTL associated with sentinel SNP (14 genes) (Online Table 12 ); and 4) GRAIL analysis of the published data (20) (16 genes) (Online Table 13 ) with "cardiac," "muscle," and "heart" as the top 3 keywords describing the observed functional connections. In total, this strategy identified 67
candidate genes at the 52 loci ( Figure 1 Figure 7) and also when compared to the same transcripts in other tissues Compared with other genes, the candidate genes van der Harst et al.
Genetic Loci Influencing Myocardial Mass S E P T E M B E R 2 7 , 2 0 1 6 : 1 4 3 5 -4 8 Table 16 ). In addition to MYBPC3, eQTL and histone modification data also suggest a potential role for NR1H3 (Online Figure 11) , as decreased expression of Table 18 ) and identified 404 significantly (false discovery rate <5%)
enriched gene sets (Online Table 19 ). Comparing the names of these sets with those of the remaining 14,057 gene sets showed an over-representation of the common key words "abnormal," "muscle,"
"heart," "cardiac," and "morphology" (Online Table 20 ). We investigated similarities among gene sets by clustering them on the basis of the correlation between scores for all genes (Online Appendix). Many of the resulting 43 meta-gene sets were correlated and relevant to cardiac biology ( Figure 5B) . As an example, we showed the correlation structure within the second most significant meta-gene set "dilated heart left ventricle" (Online Figure 12 ). When prioritizing genes on the basis of functional similarities among genes from different associated regions, DEPICT identified 35 genes (false discovery rate <5%)
at 27 of the 52 loci ( Figure 1 , Online Table 21 ).
DISCUSSION
In this study, we performed a meta-analysis of GWAS van der Harst et al.
Genetic Loci Influencing Myocardial Mass S E P T E M B E R 2 7 , 2 0 1 6 : 1 4 3 5 -4 8 independent signals within a locus. To understand genetic mechanisms and to identify candidate genes, we have studied eQTLs. Although we studied the largest set of human cardiac eQTLs available to date, the absolute number of studied samples is relatively small compared to eQTL data available in easily accessible peripheral blood. Finally, our ECG indexes are generally considered to be markers of cardiac hypertrophy; they also might reflect electrical remodeling of the action potential and not mass per se.
Nevertheless, the variables studied here harbor important prognostic information, independently from cardiac mass parameters as assessed by echocardiography (26) . This further underscores the relevance of the trait studied and the importance of understanding its genetic determinants.
CONCLUSIONS
In this study, we identified 52 genomic loci, of which 32 are novel and associated with electrically active cardiac mass. We prioritized 67 candidate genes and showed their relevance in cardiac biology using bioinformatic approaches, and we performed in vitro and In this study, a number of gene-containing loci were identified that influence a variety of abnormalities in the dysfunctional heart, myocardium, and cardiac myocytes.
Analyzing the QRS genome-wide association study results using the DEPICT (Data-Driven Expression-Prioritized Integration for Complex Traits) tool identified 43 metagene sets ( Figure 5B) ; 1 of these is the "dilated heart left ventricle," of which the effects of the individual gene sets are visualized in the illustration. The correlation substructure and the p values of this gene set are also displayed in Online Figure 12 .
J A C C V O L . 6 8 , N O . 1 3 , 2 0 1 6 van der Harst et al. 
S E P T E M B E R
2 7 , 2 0 1 6 : 1 4 3 5 -4 8
PERSPECTIVES COMPETENCY IN MEDICAL KNOWLEDGE:
Numerous genetic loci have been identified that are associated with electrocardiographic markers of ventricular hypertrophy.
TRANSLATIONAL OUTLOOK: A better understanding of the genetic pathways underlying increased myocardial mass could be used to target therapeutic interventions that improve clinical outcomes for patients with hypertension, heart failure, and various forms of congenital heart disease.
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